In addition to corticosteroid use, immunomodulatory therapies inhibiting IL6 (tocilizumab/sarilumab) and Janus kinase (JAK) are recommended for managing COVID-19, with the aim of reducing the cytokine storm or inhibiting signaling required for immune activation (57). Here, IL6 is linked to COVID-19.